Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03581396
Other study ID # 7026
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 22, 2018
Est. completion date June 2019

Study information

Verified date June 2018
Source University Hospital, Strasbourg, France
Contact Aïna VENKATASAMY,, MD
Phone 33 3 88 12 78 65
Email aina.venkatasamy@chru-strasbourg.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The symptoms of intralabyrinthine schwannomas (vertigo, deafness, instability, tinnitus) cut across the symptoms found in pressure pathologies involving the inner ear, particularly the endolymphatic hydrops.

Some publications have described dilatation of the membranous labyrinth (hydrops) in the presence of intralabyrinthine tumors.

It would be interesting to measure the size of the saccule (structure of the membranous labyrinth) in the presence of an intralabyrinthine schwannoma, to evaluate if some of the symptoms presented by the patients could be explained by the concomitant presence of an endolymphatic hydrops (accessible to drug therapy - Betahistine).


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date June 2019
Est. primary completion date June 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria

- Age> 18,

- Subject having benefited from an exploration of internal auditory canals by MRI in our service at CHU de Hautepierre between January 1, 2008 and October 1, 2017

- Presence on the MRI of the internal auditory ducts, including the realization of a high resolution fluid sequence of FIESTA-C (exploitable) type, of an intralabyrinthine schwannoma, without extension to the internal auditory canal.

- Subject who has agreed to the use of medical data for the purposes of this research.

Criteria for Non Inclusion

- Refusal of the patient to participate in the study

- Absence of high resolution fluid sequence of fast imaging employing steady state acquisition (FIESTA-C)

- Presence of movement artifacts interfering with the interpretation of the FIESTA-C sequence

- Interior surgery of the inner ear or pontocerebellar angle, without preoperative imaging Inflammatory or infectious pathology of the concomitant middle or inner ear

- Extension of schwannoma to the internal auditory canal

- Impossibility of giving the subject informed information (difficulty understanding the subject,)

- Subject under the protection of justice

- Subject under guardianship or curatorship

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Service Imagerie 1 Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Size of intralabyrinth saccules To measure saccule size (membranous labyrinth structure) in patients with intralabyrinthine schwannoma on a high resolution fluid sequence (FIESTA-C) in 3T MRI 1 hour after the realization of the MRI]